Recombinant SARS-CoV-2 (B.1.1.7, Alpha) Virus-Like Particles

• Cat.No.: VLP-348S
• Product Overview: Recombinant SARS-CoV-2 (B.1.1.7, Alpha) Virus-Like Particles without tag was expressed in HEK293.

Specification

• Species: SARS-CoV-2
• Source: HEK293
• Description: SARS-CoV-2 virus-like particles B.1.1.7 (Alpha) are composed of four structural proteins: Membrane protein (M), Nucleocapsid protein (N), Alpha-spike protein (S) and Envelope protein (E). VLPs are produced in mammalian HEK293 cells.
• Form: Liquid
• Molecular Mass: Purified SARS-CoV-2 VLPs B.1.1.7 (Alpha) was analyzed migrates about 100 kDa under reducing condition,using Mouse anti-SARS-CoV-2 Spike mAb, clone LGSV201. (Western blot)
  Purified SARS-CoV-2 VLPs B.1.1.7 (Alpha) was analyzed migrates about 48 kDa under reducing condition,using Mouse anti-SARS-CoV & CoV-2 NP mAb, clone 102-7. (Western blot)
• Storage: The product is shipped with polar packs. Upon receipt, store it immediately at -80 centigrade or lower for long term storage.
• Concentration: 1 mg/mL
• Storage Buffer: Phosphate buffered saline, pH 7.4.
• Shipping: This product is stable after storage at:
  -80 centigrade for long-term storage under sterile conditions.
  Avoid repeated free-thaw cycles. Thaw quickly using a 37 centigrade water bath immediately before use.

Gene Information

• Official Symbol: VLP
• Synonyms: Virus Like Particles; VLP